Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...

The company doesn't seem like it will generate pops in key fundamentals anytime soon.

Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

A code execution vulnerability in the Unity game engine could be exploited to achieve code execution on Android and privilege escalation on Windows. Unity is a cross-platform game engine and ...

The approval of the merger between Providus Bank and Unity Bank Plc effectively consummated the first merger under the ongoing banking recapitalisation. With barely six months to the deadline for the ...

The firm is projecting a gradual recovery of the academic market in the face of ongoing funding uncertainties and a government shutdown.

-Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, one-time therapy- -As of the August 31, 2025 data cut-off date, all seven ...

The DUP has distanced itself from comments made by the son of one of the founders of the party over being "open" to hearing "persuasive arguments" around the potential of a united Ireland. Ian Paisley ...

The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...